CLASS II ONGOING Drug recall · Reported 11 Mar 2026 · FDA Enforcement Report
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial recalled
New Life Pharma is recalling Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, distributed in Ohio. The recall was initiated on 26 Feb 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0392-2026
- FDA event ID
- 98496
- Recalling firm
- New Life Pharma, Northvale, NJ
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 26 Feb 2026
- FDA classified
- 17 Mar 2026
- Reported
- 11 Mar 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Diabetes Medication
Timeline
| 26 Feb 2026 | Recall initiated by company | |
| 11 Mar 2026 | Published in enforcement report | +13 days |
| 17 Mar 2026 | Classified by FDA | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
Where it was distributed
OH
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027
Where was it sold?
OH
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
3 other products · FDA event 98496This product is part of a recall event; the main page for the event is Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH | |
| CLASS II | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH | |
| CLASS II | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
More recalls from New Life Pharma
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
| Drug | CLASS II | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
| Drug | CLASS II | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |
Other Semaglutide Inj recalls
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled | New Life Pharma | Sterility | OH |